Switzerland An expert in the implementation of Swiss federal laws within Switzerland’s constituent cantons, Giovan Maria Zanini discusses the evolution of Swiss pharma regulatory framework and efforts to strengthen and protect the country’s world leading innovation environment. Dr. Zanini, you have been described as “the expert in the cantonal implementation of…
Taiwan Du-Shieng Chien, President & CEO of TaiRx, a Taiwan-based biopharmaceutical company focused on unmet medical needs, provides insights into the recent development of CVM 1118, a revolutionary cancer treatment targeting breakthrough mechanisms to tackle tumor development and the first drug of its kind to have already started clinical trials in…
Singapore DKSH’s VP of Healthcare in Singapore and Malaysia, Dr. Varun Sethi deconstructs the essence of what it means to be a Market Expansion Services provider, while highlighting aspects of the value chain where they can drive the most value for healthcare companies. He also comments on the strategic importance of a…
Ireland Shane Ryan, in his first month as Country Lead for Takeda Products Ireland, speaks about his mandate to position Takeda as the leader in IBD and oncology with exciting new product launches, the evolving pharmaceutical and healthcare landscape in Ireland, and the drive to help patients that motivates him every…
Mexico Alan Smithers, CEO at IFA Celtics, highlights the obesity as a national healthcare challenge and explains the company’s strategy to enlarge its capabilities to cope with the increasing needs of the patients’ and physicians’ communities. Could you please introduce yourself to our international as well as the main activities and…
Mexico Salomon Rayek, CEO at Sinbiotik, explains how the company managed to adapt its business model to the industry trends and showcases the added value of Sinbiotik when offering high quality, cost-effective and fully regulated APIs manufactured locally. Could you please introduce yourself to our international audience as well as the…
Switzerland Switzerland may have a world class healthcare system, but small adjustments are needed to ensure incentives for payer and providers are properly aligned with the patient’s ultimate quality and value of care. Dr. Cassis, could you please introduce yourself, with reference to your experience and current responsibilities in the realm…
Singapore The chairman of Singapore’s Medical Technology Industry Group, Albert Lee discusses the association’s key priorities, how they serve to advance the interests of both multinational and local members, and the key challenges that the medtech industry faces in transition from product-based to solutions-based care. Can you provide an overview of…
Ireland Dan McAlister and Ramy Michael, two of EIDA Solutions’ cofounders, tell us the exciting story behind EIDA Solutions’ rapid growth to become one of the best intelligent construction software companies for the pharmaceutical industry in Ireland, the key features of their software and their plans for internationalization to make EIDA…
Luxembourg Novartis’ newest Head for the Grand-Duchy of Luxembourg provides a fascinating insight into the Luxembourg market and reveals how this small nation has found itself in pole position for future pharmaceutical innovation. After over a decade with GSK, you joined Novartis one and half years ago. What made you join…
Switzerland Advances in delivery technology and manufacturing costs have driven a surge of activity in peptide drug development, says Thomas Früh, CEO of Bachem – the largest and most advanced peptide drug CMO in the world. Peptide therapeutics are a hot topic in the pharma industry today – what’s the story…
Philippines In an exclusive interview with Nestor Lumanas, the founder and general manager of Sannovex in the Philippines, he highlights their impeccable sales force and consistent values that have led to accelerated growth for the generic injections company over the past six years. With over 25 years of experience working in…
See our Cookie Privacy Policy Here